Literature DB >> 15500445

Analysis of normal and mutant iduronate-2-sulphatase conformation.

Emma Parkinson-Lawrence1, Christopher Turner, John Hopwood, Doug Brooks.   

Abstract

Mammalian sulphatases (EC 3.1.6) are a family of enzymes that have a high degree of similarity in amino acid sequence, structure and catalytic mechanism. IDS (iduronate-2-sulphatase; EC 3.1.6.13) is a lysosomal exo-sulphatase that belongs to this protein family and is involved in the degradation of the glycosaminoglycans heparan sulphate and dermatan sulphate. An IDS deficiency causes the lysosomal storage disorder MPS II (mucopolysaccharidosis type II). To examine the structural alterations in heat-denatured and mutant IDS, a panel of four monoclonal antibodies was raised to the denatured protein and used as probes of protein conformation. The linear sequence epitope reactivity of a polyclonal antibody raised against the native protein and the monoclonal antibodies were defined and mapped to distinct regions on the IDS protein. The antigenicity of native IDS was higher in regions without glycosylation, but reactivity was not restricted to protein surface epitopes. One monoclonal epitope was relatively surface accessible and in close proximity to an N-linked glycosylation site, while three others required additional thermal energy to expose the epitopes. The monoclonal antibodies demonstrated the capacity to differentiate progressive structural changes in IDS and could be used to characterize the severity of MPS type II in patients based on variable denatured microstates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15500445      PMCID: PMC1134805          DOI: 10.1042/BJ20040739

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

1.  Conserved core structure and active site residues in alkaline phosphatase superfamily enzymes.

Authors:  M Y Galperin; M J Jedrzejas
Journal:  Proteins       Date:  2001-12-01

2.  Monoclonal antibodies as a probe for the unfolding of porcine growth hormone.

Authors:  Vitaliano Borromeo; Daniela Gaggioli; Anna Berrini; Camillo Secchi
Journal:  J Immunol Methods       Date:  2003-01-15       Impact factor: 2.303

3.  Monoclonal antibodies specific for the native, disease-associated isoform of the prion protein.

Authors:  C Korth; P Streit; B Oesch
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

4.  Multiple forms of iduronate 2-sulphate sulphatase in human tissues and body fluids.

Authors:  I M Archer; P S Harper; F S Wusteman
Journal:  Biochim Biophys Acta       Date:  1982-11-09

Review 5.  Review: genetics of steroid sulphatase deficiency and X-linked ichthyosis.

Authors:  M A Crawfurd
Journal:  J Inherit Metab Dis       Date:  1982       Impact factor: 4.982

6.  Crystal structure of an enzyme-substrate complex provides insight into the interaction between human arylsulfatase A and its substrates during catalysis.

Authors:  R von Bülow; B Schmidt; T Dierks; K von Figura; I Usón
Journal:  J Mol Biol       Date:  2001-01-12       Impact factor: 5.469

7.  Iduronate-2-sulphatase protein detection in plasma from mucopolysaccharidosis type II patients.

Authors:  Emma J Parkinson; Viv Muller; John J Hopwood; Doug A Brooks
Journal:  Mol Genet Metab       Date:  2004-01       Impact factor: 4.797

8.  X-linked ichthyosis and X-linked placental sulfatase deficiency: a disease entity. Histochemical observations.

Authors:  A C Jöbsis; W P De Groot; A J Tigges; H W De Bruijn; Y Rijken; A E Meijer; A Marinkovic-Ilsen
Journal:  Am J Pathol       Date:  1980-05       Impact factor: 4.307

Review 9.  Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I.

Authors:  Revecca Kakavanos; Chris T Turner; John J Hopwood; Emil D Kakkis; Doug A Brooks
Journal:  Lancet       Date:  2003-05-10       Impact factor: 79.321

10.  Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: identification of 13 novel mutations.

Authors:  Chi Hwa Kim; Hye Zin Hwang; Seng Mi Song; Kyung Hoon Paik; Eun Kyung Kwon; Kwang Bin Moon; Jeong Hyeok Yoon; Cheol Kyu Han; Dong-Kyu Jin
Journal:  Hum Mutat       Date:  2003-04       Impact factor: 4.878

View more
  4 in total

1.  A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome.

Authors:  Yo Kyung Chung; Young Bae Sohn; Jong Mun Sohn; Jieun Lee; Mi Sun Chang; Younghee Kwun; Chi Hwa Kim; Jin Young Lee; Yeon Joo Yook; Ah-Ra Ko; Dong-Kyu Jin
Journal:  Glycoconj J       Date:  2014-04-30       Impact factor: 2.916

2.  SAAMP 2.0: An algorithm to predict genotype-phenotype correlation of lysosomal storage diseases.

Authors:  L Ou; M J Przybilla; C B Whitley
Journal:  Clin Genet       Date:  2018-03-05       Impact factor: 4.438

3.  Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy.

Authors:  Vinicia Assunta Polito; Serena Abbondante; Roman S Polishchuk; Edoardo Nusco; Rosaria Salvia; Maria Pia Cosma
Journal:  Hum Mol Genet       Date:  2010-09-27       Impact factor: 6.150

4.  Structural Basis of Mucopolysaccharidosis Type II and Construction of a Database of Mutant Iduronate 2-Sulfatases.

Authors:  Seiji Saito; Kazuki Ohno; Torayuki Okuyama; Hitoshi Sakuraba
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.